About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ets2tm3Rgo
targeted mutation 3, Robert G Oshima
MGI:3769393
Summary 8 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Ets2tm3Rgo/Ets2tm3Rgo involves: 129S1/Sv * 129X1/SvJ MGI:3769395
cn2
Ets2tm3Rgo/Ets2tm3Rgo involves: 129S1/Sv * 129X1/SvJ MGI:3769398
cn3
Ets2tm3Rgo/Ets2tm3Rgo
Meox2tm1(cre)Sor/Meox2+
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ MGI:3769399
cn4
Ets2tm2Rgo/Ets2tm3Rgo
Meox2tm1(cre)Sor/Meox2+
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ MGI:3769401
cn5
Ets2tm3Rgo/Ets2tm3.1Rgo
Meox2tm1(cre)Sor/?
Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul/?
involves: 129S4/SvJae * C57BL/6 * FVB/N MGI:3615252
cn6
Ets2tm3Rgo/Ets2+
Meox2tm1(cre)Sor/?
Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul/?
involves: 129S4/SvJae * C57BL/6 * FVB/N MGI:3615263
cn7
Ets2tm3Rgo/Ets2tm3Rgo
Meox2tm1(cre)Sor/?
Tg(MMTV-cre)7Mul/?
involves: 129S4/SvJaeSor * FVB/N MGI:3615264
cn8
Ets2tm3Rgo/Ets2+
Meox2tm1(cre)Sor/?
Tg(MMTV-cre)7Mul/?
involves: 129S4/SvJaeSor * FVB/N MGI:3615265


Genotype
MGI:3769395
hm1
Allelic
Composition
Ets2tm3Rgo/Ets2tm3Rgo
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ets2tm3Rgo mutation (1 available); any Ets2 mutation (39 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice have normal development and lifespan




Genotype
MGI:3769398
cn2
Allelic
Composition
Ets2tm3Rgo/Ets2tm3Rgo
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ets2tm3Rgo mutation (1 available); any Ets2 mutation (39 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
embryo
• when transfected with an adenovirus Cre, trophoblast stem cells exhibit reduced growth and self-renewal
• however, trophoblast cells transfected with an adenovirus Cre differentiate normally




Genotype
MGI:3769399
cn3
Allelic
Composition
Ets2tm3Rgo/Ets2tm3Rgo
Meox2tm1(cre)Sor/Meox2+
Genetic
Background
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ets2tm3Rgo mutation (1 available); any Ets2 mutation (39 available)
Meox2tm1(cre)Sor mutation (3 available); any Meox2 mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging

embryo
• at E7.5, yolk sacs are cone-shaped

growth/size/body




Genotype
MGI:3769401
cn4
Allelic
Composition
Ets2tm2Rgo/Ets2tm3Rgo
Meox2tm1(cre)Sor/Meox2+
Genetic
Background
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ets2tm2Rgo mutation (0 available); any Ets2 mutation (39 available)
Ets2tm3Rgo mutation (1 available); any Ets2 mutation (39 available)
Meox2tm1(cre)Sor mutation (3 available); any Meox2 mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice die around mid-gestation




Genotype
MGI:3615252
cn5
Allelic
Composition
Ets2tm3Rgo/Ets2tm3.1Rgo
Meox2tm1(cre)Sor/?
Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul/?
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ets2tm3.1Rgo mutation (0 available); any Ets2 mutation (39 available)
Ets2tm3Rgo mutation (1 available); any Ets2 mutation (39 available)
Meox2tm1(cre)Sor mutation (3 available); any Meox2 mutation (18 available)
Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• delayed onset of mammary tumors with a median onset of 174 days, a significant delay of 37 days from control group
• once tumors appeared, the rate of tumor growth was not detectably altered

endocrine/exocrine glands
• delayed onset of mammary tumors with a median onset of 174 days, a significant delay of 37 days from control group
• once tumors appeared, the rate of tumor growth was not detectably altered
• the epithelial hyperplasia of mutant mice filled less of the mammary fat pad than control

integument
• delayed onset of mammary tumors with a median onset of 174 days, a significant delay of 37 days from control group
• once tumors appeared, the rate of tumor growth was not detectably altered
• the epithelial hyperplasia of mutant mice filled less of the mammary fat pad than control




Genotype
MGI:3615263
cn6
Allelic
Composition
Ets2tm3Rgo/Ets2+
Meox2tm1(cre)Sor/?
Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul/?
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ets2tm3Rgo mutation (1 available); any Ets2 mutation (39 available)
Meox2tm1(cre)Sor mutation (3 available); any Meox2 mutation (18 available)
Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• onset of mammary tumors with a median onset of 137 days
• this mutant was used as control for Ets2tm3Rgo/Ets2tm3.1Rgo Meox2tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis

endocrine/exocrine glands
• onset of mammary tumors with a median onset of 137 days
• this mutant was used as control for Ets2tm3Rgo/Ets2tm3.1Rgo Meox2tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis

integument
• onset of mammary tumors with a median onset of 137 days
• this mutant was used as control for Ets2tm3Rgo/Ets2tm3.1Rgo Meox2tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis




Genotype
MGI:3615264
cn7
Allelic
Composition
Ets2tm3Rgo/Ets2tm3Rgo
Meox2tm1(cre)Sor/?
Tg(MMTV-cre)7Mul/?
Genetic
Background
involves: 129S4/SvJaeSor * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ets2tm3Rgo mutation (1 available); any Ets2 mutation (39 available)
Meox2tm1(cre)Sor mutation (3 available); any Meox2 mutation (18 available)
Tg(MMTV-cre)7Mul mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• onset of mammary tumors with a median onset of 132 days
• this mutant was used as control for Ets2tm3Rgo/Ets2tm3.1Rgo Meox2tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis

endocrine/exocrine glands
• onset of mammary tumors with a median onset of 132 days
• this mutant was used as control for Ets2tm3Rgo/Ets2tm3.1Rgo Meox2tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis

integument
• onset of mammary tumors with a median onset of 132 days
• this mutant was used as control for Ets2tm3Rgo/Ets2tm3.1Rgo Meox2tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis




Genotype
MGI:3615265
cn8
Allelic
Composition
Ets2tm3Rgo/Ets2+
Meox2tm1(cre)Sor/?
Tg(MMTV-cre)7Mul/?
Genetic
Background
involves: 129S4/SvJaeSor * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ets2tm3Rgo mutation (1 available); any Ets2 mutation (39 available)
Meox2tm1(cre)Sor mutation (3 available); any Meox2 mutation (18 available)
Tg(MMTV-cre)7Mul mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• onset of mammary tumors with a median onset of 132 days
• this mutant was used as control for Ets2tm3Rgo/Ets2tm3.1Rgo Meox2tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis

integument
• onset of mammary tumors with a median onset of 132 days
• this mutant was used as control for Ets2tm3Rgo/Ets2tm3.1Rgo Meox2tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis

endocrine/exocrine glands
• onset of mammary tumors with a median onset of 132 days
• this mutant was used as control for Ets2tm3Rgo/Ets2tm3.1Rgo Meox2tm1(cre)Sor /? Tg(MMTV-PyVT*Y315F,Y322F)Db-1Mul/? mice to test the effect of Ets2 deficiency on mammary tumrigenesis





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory